133 results
8-K
EX-99.1
ZOM
Zomedica Corp
4 Apr 24
Results of Operations and Financial Condition
12:10pm
, risks relating to the safety and efficacy of our products, the use of our products, intellectual property protection, including our ability to develop
8-K
EX-99.1
ZOM
Zomedica Corp
15 Mar 24
Zomedica Provides Corporate NYSE American Listing Update
7:46am
relating to the safety and efficacy of our products, the use of our products, intellectual property protection, risks related to the COVID-19
DEFA14A
ZOM
Zomedica Corp
6 Feb 24
Additional proxy soliciting materials
5:14pm
infringement risks, risks relating to any required clinical trials and regulatory approvals, risks relating to the safety and efficacy of our
DEFA14A
ZOM
Zomedica Corp
31 Jan 24
Additional proxy soliciting materials
8:00am
approvals, risks relating to the safety and efficacy of our products, the use of our products, intellectual property protection, risks related
DEFA14A
eczastyt oem7ve
26 Jan 24
Additional proxy soliciting materials
12:00am
DEFA14A
qshyu
17 Jan 24
Additional proxy soliciting materials
4:01pm
8-K
EX-99.1
0nbia
13 Nov 23
Results of Operations and Financial Condition
4:16pm
8-K
EX-99.1
wvc8yu v4h00dnn4d
10 Oct 23
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
pw5xp
10 Oct 23
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
2mjc17lts
13 Sep 23
Zomedica Provides Corporate Update
5:58pm
8-K
EX-99.1
sraptlc
6 Sep 23
Zomedica Closes Acquisition of Structured Monitoring Products adding revolutionary
8:18am
8-K
EX-2.1
5bnggb
6 Sep 23
Zomedica Closes Acquisition of Structured Monitoring Products adding revolutionary
8:18am
8-K
EX-99.1
kwska32
10 Aug 23
Results of Operations and Financial Condition
4:22pm
8-K
EX-99.1
y41x7lij fsr
11 May 23
Results of Operations and Financial Condition
4:27pm
8-K
EX-99.1
ixd 0cfp2v99
9 May 23
Other Events
8:57am
8-K
EX-99.1
tgph3 6d05i
14 Nov 22
Results of Operations and Financial Condition
4:24pm
8-K
EX-99.1
mkx s0wj2lzuvl0
24 Aug 22
Zomedica Appoints Dr. Pamela Nichols, DVM to Board of Directors
4:57pm
8-K
EX-99.1
b1mc4jy
15 Aug 22
Zomedica Announces Second Quarter 2022 Financial Results of $4.2 Million
6:12pm